Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Clinical Research›Control Groups
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Control Groups

Clinical Research · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

Groups that serve as a standard for comparison in experimental studies.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (993 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Groups that serve as a standard for comparison in experimental studies. They are similar in relevant characteristics to the experimental group but do not receive the experimental intervention.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Control Group; Group, Control; Groups, Control.

Where it fits in the MeSH classification

Broader topics
Epidemiologic Research Design; Research Design
See also
Controlled Clinical Trials as Topic

Research landscape

PubMed indexes 2,168 records tagged with the MeSH heading “Control Groups” (counts retrieved 2026-10-29). 485 of them (22.4%) were published from 2020 onward, and the busiest period so far is 2000-2009 with 781 records.

Reviews account for 233 records (10.7%) and meta-analyses for 73. Randomized controlled trials number 158 (7.3%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 449 records; 2000-2009: 781 records; 2010-2019: 453 records; 2020 onward: 485 records449through 19997812000-20094532010-20194852020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999449
2000-2009781
2010-2019453
2020 onward485
Share of records by publication typeReviews: 10.7 percent; Meta-analyses: 3.4 percent; Randomized controlled trials: 7.3 percentReviews10.7% (233)Meta-analyses3.4% (73)Randomized controlled trials7.3% (158)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 2,168 PubMed records
TypeRecordsShare
Reviews23310.7%
Meta-analyses733.4%
Randomized controlled trials1587.3%

Method: PubMed query "Control Groups"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in clinical research

Research methods determine how much a result can be trusted. Randomized trials guard against confounding, systematic reviews and meta-analyses combine many studies, and observational designs are valuable but can show only association. Reporting standards, trial registration and pre-specified outcomes reduce bias. When reading about a method, ask what problem it is designed to solve and which problems it does not solve.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Update in the methodology of the chronic stress paradigm: internal control matters
Strekalova T, Couch Y, Kholod N, Boyks M, Malin D, Leprince P, et al.
2011Review article
Design not recorded in structured metadata
123cc by
PMID 21524310 · DOI · PMC3111355
Influence of control group on effect size in trials of acupuncture for chronic pain: a secondary analysis of an individual patient data meta-analysis
MacPherson H, Vertosick E, Lewith G, Linde K, Sherman KJ, Witt CM, et al.
2014Meta-analysis
Design not recorded in structured metadata
86cc by
PMID 24705624 · DOI · PMC3976298
Control group design, contamination and drop-out in exercise oncology trials: a systematic review
Steins Bisschop CN, Courneya KS, Velthuis MJ, Monninkhof EM, Jones LW, Friedenreich C, et al.
2015Systematic review
Design not recorded in structured metadata
74cc by
PMID 25815479 · DOI · PMC4376879
Evaluation of Time-related Bias With Non-user Control
Morita H, Matsuura K, Seya N, Taguri M
2026Research article
Design not recorded in structured metadata
2cc by
PMID 41110963 · DOI · PMC12975769

Update in the methodology of the chronic stress paradigm: internal control matters [1]

Review article Strekalova T, Couch Y, Kholod N, Boyks M, Malin D, Leprince P, et al. · · 2011 · cited 123 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
To date, the reliability of induction of a depressive-like state using chronic stress models is confronted by many methodological limitations.
Closing excerpt
These results argue for the use of a subgroup of individuals who are negative for the induction of a depressive phenotype during experimental paradigms of depression as an internal control, for more refined modeling of this disorder in animals.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (188 words)

To date, the reliability of induction of a depressive-like state using chronic stress models is confronted by many methodological limitations. We believe that the modifications to the stress paradigm in mice proposed herein allow some of these limitations to be overcome. Here, we discuss a variant of the standard stress paradigm, which results in anhedonia. This anhedonic state was defined by a decrease in sucrose preference that was not exhibited by all animals. As such, we propose the use of non-anhedonic, stressed mice as an internal control in experimental mouse models of depression. The application of an internal control for the effects of stress, along with optimized behavioural testing, can enable the analysis of biological correlates of stress-induced anhedonia versus the consequences of stress alone in a chronic-stress depression model. This is illustrated, for instance, by distinct physiological and molecular profiles in anhedonic and non-anhedonic groups subjected to stress. These results argue for the use of a subgroup of individuals who are negative for the induction of a depressive phenotype during experimental paradigms of depression as an internal control, for more refined modeling of this disorder in animals.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 21524310 · DOI · PMC3111355

Influence of control group on effect size in trials of acupuncture for chronic pain: a secondary analysis of an individual patient data meta-analysis [2]

Meta-analysis MacPherson H, Vertosick E, Lewith G, Linde K, Sherman KJ, Witt CM, et al. · · 2014 · cited 86 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundIn a recent individual patient data meta-analysis, acupuncture was found to be superior to both sham and non-sham controls in patients with chronic pain.
Closing excerpt
We recommend that this type of sham be avoided.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (291 words)

BackgroundIn a recent individual patient data meta-analysis, acupuncture was found to be superior to both sham and non-sham controls in patients with chronic pain. In this paper we identify variations in types of sham and non-sham controls used and analyze their impact on the effect size of acupuncture.MethodsBased on literature searches of acupuncture trials involving patients with headache and migraine, osteoarthritis, and back, neck and shoulder pain, 29 trials met inclusion criteria, 20 involving sham controls (n = 5,230) and 18 non-sham controls (n = 14,597). For sham controls, we analysed non-needle sham, penetrating sham needles and non-penetrating sham needles. For non-sham controls, we analysed non-specified routine care and protocol-guided care. Using meta-regression we explored impact of choice of control on effect of acupuncture.FindingsAcupuncture was significantly superior to all categories of control group. For trials that used penetrating needles for sham control, acupuncture had smaller effect sizes than for trials with non-penetrating sham or sham control without needles. The difference in effect size was -0.45 (95% C.I. -0.78, -0.12; p = 0.007), or -0.19 (95% C.I. -0.39, 0.01; p = 0.058) after exclusion of outlying studies showing very large effects of acupuncture. In trials with non-sham controls, larger effect sizes associated with acupuncture vs. non-specified routine care than vs. protocol-guided care. Although the difference in effect size was large (0.26), it was not significant with a wide confidence interval (95% C.I. -0.05, 0.57, p = 0.1).ConclusionAcupuncture is significantly superior to control irrespective of the subtype of control. While the choice of control should be driven by the study question, our findings can help inform study design in acupuncture, particularly with respect to sample size. Penetrating needles appear to have important physiologic activity. We recommend that this type of sham be avoided.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 24705624 · DOI · PMC3976298

Control group design, contamination and drop-out in exercise oncology trials: a systematic review [3]

Systematic review Steins Bisschop CN, Courneya KS, Velthuis MJ, Monninkhof EM, Jones LW, Friedenreich C, et al. · · 2015 · cited 74 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
PurposeImportant considerations for exercise trials in cancer patients are contamination and differential drop-out among the control group members that might jeopardize the internal validity.
Closing excerpt
The present findings can be considered when designing future exercise-oncology trials.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (277 words)

PurposeImportant considerations for exercise trials in cancer patients are contamination and differential drop-out among the control group members that might jeopardize the internal validity. This systematic review provides an overview of different control groups design characteristics of exercise-oncology trials and explores the association with contamination and drop-out rates.MethodsRandomized controlled exercise-oncology trials from two Cochrane reviews were included. Additionally, a computer-aided search using Medline (Pubmed), Embase and CINAHL was conducted after completion date of the Cochrane reviews. Eligible studies were classified according to three control group design characteristics: the exercise instruction given to controls before start of the study (exercise allowed or not); and the intervention the control group was offered during (any (e.g., education sessions or telephone contacts) or none) or after (any (e.g., cross-over or exercise instruction) or none) the intervention period. Contamination (yes or no) and excess drop-out rates (i.e., drop-out rate of the control group minus the drop-out rate exercise group) were described according to the three design characteristics of the control group and according to the combinations of these three characteristics; so we additionally made subgroups based on combinations of type and timing of instructions received.Results40 exercise-oncology trials were included based on pre-specified eligibility criteria. The lowest contamination (7.1% of studies) and low drop-out rates (excess drop-out rate -4.7±9.2) were found in control groups offered an intervention after the intervention period. When control groups were offered an intervention both during and after the intervention period, contamination (0%) and excess drop-out rates (-10.0±12.8%) were even lower.ConclusionsControl groups receiving an intervention during and after the study intervention period have lower contamination and drop-out rates. The present findings can be considered when designing future exercise-oncology trials.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 25815479 · DOI · PMC4376879

Evaluation of Time-related Bias With Non-user Control [4]

Research article Morita H, Matsuura K, Seya N, Taguri M · · 2026 · cited 2 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundIn observational studies estimating the association between treatment and time-to-event outcomes, time-related biases can substantially impact results.
Closing excerpt
ConclusionTo reduce time-related biases, it is crucial for researchers to carefully define an appropriate time-zero, especially when using a non-user control group.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (237 words)

BackgroundIn observational studies estimating the association between treatment and time-to-event outcomes, time-related biases can substantially impact results. Immortal time bias is one of such biases, and two types are known: misclassified immortal time bias and excluded immortal time bias. These biases often arise from incorrect time-zero definition, especially with non-user controls. This study aims to illustrate immortal time bias in non-user controls using formulas, simulations, and real-world data.MethodsFor our simulations, we considered two scenarios: one with no confounding and no treatment effect, and the other with time-dependent confounding. We compare three different settings of time-zero for treatment and control groups. Method 1: Both groups were followed from cohort entry date (CED). Method 2: The treatment group was followed from treatment initiation date (TID), while the non-user group was followed from CED. Method 3: The treatment group was followed from TID, and non-users were matched to treatment patients, followed from the corresponding TID of their matched patient.ResultsOur simulation showed that both method 1 and method 2 can exhibit large biases in the estimated treatment effect due to immortal time bias. The magnitude of the bias is greater for method 1 than for method 2. On the other hand, method 3 showed almost no bias. Even in the presence of time-dependent confounding, method 3 did not introduce bias.ConclusionTo reduce time-related biases, it is crucial for researchers to carefully define an appropriate time-zero, especially when using a non-user control group.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41110963 · DOI · PMC12975769

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Placebo response in studies of major depression: variable, substantial, and growing [5]
    Walsh BT, Seidman SN, Sysko R, Gould M · JAMA · 2002 · cited 753 times (Europe PMC)
  • Research article Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions [6]
    Freedland KE, Mohr DC, Davidson KW, Schwartz JE · Psychosom Med · 2011 · cited 248 times (Europe PMC)
  • Research article Methodological issues in group-matching designs: alpha levels for control variable comparisons and measurement characteristics of control and target variables [7]
    Mervis CB, Klein-Tasman BP · J Autism Dev Disord · 2004 · cited 159 times (Europe PMC)
  • Research article Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework [8]
    Gold SM, Enck P, Hasselmann H, Friede T, Hegerl U, Mohr DC, et al. · Lancet Psychiatry · 2017 · cited 135 times (Europe PMC)
  • Research article A guide to interpretation of studies investigating subgroups of responders to physical therapy interventions [9]
    Hancock M, Herbert RD, Maher CG · Phys Ther · 2009 · cited 121 times (Europe PMC)
  • Research article Biobanking of CSF: international standardization to optimize biomarker development [10]
    Teunissen CE, Tumani H, Engelborghs S, Mollenhauer B · Clin Biochem · 2014 · cited 115 times (Europe PMC)

References

  1. Strekalova T, Couch Y, Kholod N, Boyks M, Malin D, Leprince P, et al.. Update in the methodology of the chronic stress paradigm: internal control matters. . 2011. PMID 21524310 · DOI · PMC3111355
  2. MacPherson H, Vertosick E, Lewith G, Linde K, Sherman KJ, Witt CM, et al.. Influence of control group on effect size in trials of acupuncture for chronic pain: a secondary analysis of an individual patient data meta-analysis. . 2014. PMID 24705624 · DOI · PMC3976298
  3. Steins Bisschop CN, Courneya KS, Velthuis MJ, Monninkhof EM, Jones LW, Friedenreich C, et al.. Control group design, contamination and drop-out in exercise oncology trials: a systematic review. . 2015. PMID 25815479 · DOI · PMC4376879
  4. Morita H, Matsuura K, Seya N, Taguri M. Evaluation of Time-related Bias With Non-user Control. . 2026. PMID 41110963 · DOI · PMC12975769
  5. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002. PMID 11939870 · DOI
  6. Freedland KE, Mohr DC, Davidson KW, Schwartz JE. Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom Med. 2011. PMID 21536837 · DOI · PMC3091006
  7. Mervis CB, Klein-Tasman BP. Methodological issues in group-matching designs: alpha levels for control variable comparisons and measurement characteristics of control and target variables. J Autism Dev Disord. 2004. PMID 15098952 · DOI
  8. Gold SM, Enck P, Hasselmann H, Friede T, Hegerl U, Mohr DC, et al.. Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry. 2017. PMID 28396067 · DOI
  9. Hancock M, Herbert RD, Maher CG. A guide to interpretation of studies investigating subgroups of responders to physical therapy interventions. Phys Ther. 2009. PMID 19465372 · DOI
  10. Teunissen CE, Tumani H, Engelborghs S, Mollenhauer B. Biobanking of CSF: international standardization to optimize biomarker development. Clin Biochem. 2014. PMID 24389077 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Random AllocationClinical Research
  • Sample SizeClinical Research
  • Research DesignClinical Research
  • Focus GroupsClinical Research
  • Lost to Follow-UpClinical Research
  • Patient SelectionClinical Research

All 98 articles in Clinical Research →

At a glance

2,168
PubMed records on this heading
22%
published since 2020
233
review articles
158
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Random AllocationClinical Research
  • Sample SizeClinical Research
  • Research DesignClinical Research
  • Focus GroupsClinical Research
  • Lost to Follow-UpClinical Research

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support